Franz Knauseder

APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria.

APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria.

APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria.